Nobivac Ducat

Cats:
Very common
(>1 animal / 10 animals treated):
Injection site swelling.
Common
(1 to 10 animals / 100 animals
treated):
Elevated temperature.
2Rare
(1 to 10 animals / 10,000 animals
treated):
Hypersensitivity reactions (e.g. pruritus, dyspnoea,
vomiting, diarrhoea and collapse including
anaphylaxis).
Lethargy.
Very rare
(<1 animal / 10,000 animals treated,
including isolated reports):
Injection site pain.
Febrile limping syndrome reactions in kittens.
1
A local swelling 5 mm), sometimes painful, may be observed at the injection site
for one day post-vaccination.
Elevated body temperature (up to 40 °C) may occur for 1-2 days post vaccination.
Sometimes fatal. If such a reaction occurs, appropriate treatment should be
administered without delay.
Lethargy may be observed during the first day after vaccination.
As reported in the literature, febrile limping syndrome reactions in kittens may occur
after the use of any vaccine containing a feline calicivirus component.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See section “Contact details”
of the package leaflet.